Programa | Afiliación | Cumplimiento | Completing rateiii
|
|---|---|---|---|
Medically approved tobacco cessation program
| 191
| 60
| 31%
|
Medically directed weight management program
| 108
| 70
| 65%
|
Medically approved substance abuse program
| 55
| 15
| 27%
|
Evaluación de riesgos de salud
| 75,671
| 75,671
| 100%
|
Adult well visit program
| 37,475
| 37,475
| 100% |
Programa de atención para el bienestar del niño
| 183,576
| 183,576
| 100% |
Pruebas de detección de cáncer cervical
| 14,553
| 14,553
| 100%
|
Pruebas de detección de cáncer colorrectal
| 7,207
| 7,207
| 100%
|
Mamografía
| 7,394
| 7,394
| 100%
|
Programa HumanaBeginnings
| 5,099
| 3,218
| 63%
|
Prenatal care visit
| 12,032
| 12,032
| 100% |
Postpartum care visit
| 4,309
| 4,309
| 100% |
HRA completion by diagnosisiv for Q1 & Q2 Fiscal Year 2024–2025 (July 1, 2024 thru December 31, 2024)
Diagnóstico | AHCA benchmark requirement
| Humana completion rate
|
|---|---|---|
Embarazo | 70% | 63%
|
SMI
| 50% | 55%
|
Diabetes
| 50% | 69% |
Asthma (Asma)
| 50% | 42%
|
HRA completed by diagnosisiv for Q3 & Q4 Fiscal Year 2024–2025 (January 1, 2025 thru June 30, 2025)
New contract effective February 1, 2025 with new benchmarks and additional diagnosis.
Diagnóstico | AHCA benchmark requirement
| Humana completion rate
|
|---|---|---|
Embarazo | 80% | 54% |
iBudget waiver
| 80% | 16% |
SMI | 80% | 27% |
HIV/AIDS (VIH/SIDA) | 80% | 36% |
SP SMI | 90% | 58% |
SP VIH/SIDA | 90% | 69% |
Cáncer | 80% | 42% |
Depresión | 80% | 54% |
Diabetes | 80% | 52% |
Asthma (Asma) | 80% | 30% |